Invention Grant
US08492557B2 Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
有权
[3-(1-(1H-咪唑-4-基)乙基)-2-甲基苯基]甲醇的酯前体药物
- Patent Title: Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
- Patent Title (中): [3-(1-(1H-咪唑-4-基)乙基)-2-甲基苯基]甲醇的酯前体药物
-
Application No.: US13233891Application Date: 2011-09-15
-
Publication No.: US08492557B2Publication Date: 2013-07-23
- Inventor: Ken Chow , Liming Wang , Michael E. Garst , John E. Donello , Daniel W. Gil , Mohammad I. Dibas
- Applicant: Ken Chow , Liming Wang , Michael E. Garst , John E. Donello , Daniel W. Gil , Mohammad I. Dibas
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Doina G. Ene
- Main IPC: C07D233/64
- IPC: C07D233/64 ; A61K31/216
![Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol](/abs-image/US/2013/07/23/US08492557B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to novel compounds, ester pro-drugs of [3-(1-1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals in the treatment of conditions mediated by adrenergic receptors.
Public/Granted literature
- US20120122945A1 ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL Public/Granted day:2012-05-17
Information query